ctrl K

Watchlist Price Alert

Mirum Pharmaceuticals Inc... (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

50.30

0.67 (1.35%)

At close: Jun 16, 2025, 3:59 PM

Mirum Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	336.89M	186.37M	77.06M	19.14M	n/a	n/a	n/a
Cost of Revenue	81.64M	47.04M	12.37M	1.9M	623K	324K	n/a
Gross Profit	255.25M	139.34M	64.69M	17.23M	-623K	-324K	n/a
Operating Income	-87.61M	-109.15M	-131.22M	-173.41M	-104.3M	-54.74M	-2.92M
Interest Income	13.79M	13.73M	3.86M	366K	1.56M	2.23M	87K
Pretax Income	-86.91M	-162.42M	-142.07M	-83.95M	-103.26M	-52.53M	-17.35M
Net Income	-87.94M	-163.41M	-135.66M	-83.99M	-103.27M	-52.55M	-17.35M
Selling & General & Admin	202.22M	145.88M	89.07M	59.22M	22.69M	11.75M	585K
Research & Development	140.63M	102.61M	106.84M	131.43M	81.61M	42.99M	2.33M
Other Expenses	n/a	n/a	365K	107.42M	-192K	-21K	n/a
Operating Expenses	342.85M	248.49M	195.91M	190.65M	104.3M	54.74M	2.92M
Interest Expense	14.31M	15.11M	15.98M	17.59M	335K	n/a	n/a
Selling & Marketing Expenses	n/a	6.3M	72.11M	9.2M	n/a	n/a	-292.5K
Cost & Expenses	424.49M	295.53M	208.28M	192.55M	104.3M	54.74M	2.92M
Income Tax Expense	1.03M	991K	-6.41M	37K	6K	21K	-4.37M
Shares Outstanding (Basic)	47.52M	40.89M	33.84M	30.32M	25.25M	22.99M	22.99M
Shares Outstanding (Diluted)	47.52M	40.89M	33.84M	30.32M	25.25M	22.99M	22.99M
EPS (Basic)	-1.85	-4	-4.01	-2.77	-4.09	-2.29	-0.75
EPS (Diluted)	-1.85	-4	-4.01	-2.77	-4.09	-2.29	-0.75
EBITDA	-48.97M	-136.49M	-122.41M	-65.39M	-102.31M	-52.21M	-17.33M
EBIT	-72.6M	-147.32M	-126.09M	-66.36M	-102.93M	-52.53M	-17.33M
Depreciation & Amortization	23.63M	10.83M	3.68M	975K	623K	324K	4.37M